Article

Standard Skin Tests for Antibiotic Allergies Are Ineffective, Study Finds

Author(s):

Traditional skin tests that are used to determine allergies to the common antibiotic, amoxicillin, don’t actually work, according to new research findings.

Traditional skin tests that are used to determine allergies to the common antibiotic amoxicillin don’t actually work, according to new research findings.

Moshe Ben-Shoshan, MD, allergist at the Montreal Children’s Hospital at the McGill University Health Centre (RI-MUHC) in Montreal, discovered that oral provocation or challenge test (PC), with appropriate follow-up, was a safer and more efficient screening method for diagnosing non-fatal reactions to amoxicillin in children.

JAMA Pediatrics

The study results were published in .

“Our study suggests that skin tests are essentially useless as diagnostic tests, and that we should go directly to the graded provocation test that is highly sensitive and specific. This is a game-changer in the way physicians assess amoxicillin allergy in children given the fact that skin tests are still the recommended screening method in hospitals,” Ben-Shoshan said in a news release.

The research team conducted a study involving 818 children who presented with a rash suspected from an allergic reaction to amoxicillin.

The PC tests were conducted with the suspected allergen; challenge tests were performed in a hospital or clinic to safely manage any serious reactions.

All the study participants underwent PC tests — 94.1% were tolerant to the graded PC. Additionally, only 17 experienced an immediate positive reaction to amoxicillin and 31 had non-immediate reactions that developed more than one hour after the challenge.

The researchers noted that this was the first study to actually determine the percentage of immediate and non-immediate amoxicillin allergy. “We showed that in children with a negative PC, amoxicillin can be safety used in the future, although under 10% could develop mild cutaneous symptoms upon subsequent exposure.”

Related Videos
Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD
Methods to Manage Psoriasis Using Oral Therapies, with Andrea Murina, MD
2 Additional Clinical Pearls for Dermatologists, with Eingun James Song, MD
2 Helpful Clinical Tips for Dermatologists, with Eingun James Song, MD
What Are Some Other Methods To Manage Skin Cancer Outside of Biopsies?
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
© 2024 MJH Life Sciences

All rights reserved.